PER.AX · PERCHERON THERAPEUTICS LIMITED
Australia · RS rating 37 · As of 2026-10-14
| Price | 0.00 AUD |
|---|---|
| 1-day change | -12.5% |
| RS rating (overall / 1M / 3M / 12M) | 37 / 11 / 83 / 16 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 24 / 13 / 20 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +65.0% |
| Market cap (USD) | $5.1M |